2Litovitz TL, Clark LR, Soloway RA. 1993 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System[J]. Am J Emerg Med, 1994,12(5) :546 -584.
3Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System [ J]. Am J Emerg Med, 2005,23 ( 5 ) :589 - 666.
4Austin T, Nelson, BS, Joshua D, et al. Ingestion of superwarfarin leading to coagulopathy : a case report and review of the literature [ J ]. Med Gen Med, 2006,8(4) : 41.
5Bachmann KA, Sullivan TJ. Dispositional and pharmacodynamic characteristics of broifacoum in warfarin - sensitive rats [ J ]. Pharmacology, 1983,27(5) :281 -288.
6Weitzel JN, Sadowski JA, Furie BC, et al. Surreptitious ingestion of a long - acting vitamin K antagonist/ rodenticide , brodifacoum : clinical and metabolic studies of three cases [ J ]. Blood, 1990,76 (12) : 2555 - 2559.
7Prybys KM. Life - threatening superwarfarin ingestion in a second trimester pregnancy[ J ]. J Toxicol Clin Toxicol, 1996,34 (5) :567.
8MICHEAL, ELIZABETH M. VAN, MICHEAL H. A 40 -Year -old woman with epistaxis, hematemesis and altered mental status [J]. New Eng J Med. 2007,365:174 -182.
9Weitzel J N, Sadowski J A, Furie B C, et al. Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases [J]. Blood, 1990,76(12) :2555-2559.
10Prybys K M. Life-threatening superwarfarin ingestion in a secondtdmester pregnancy[J]. Toxieol Clin Toxicol, 1996, 34(5) :567.
